Coral Laboratories Ltd Financials

Coral Laboratories Ltd Financial Statement

Coral Laboratories Ltd Income Statement

Quarterly

Annual

*All values are in Rs. Cr

Particulars	Sep 2024	Jun 2024	Mar 2024
Revenue	34.77	33.22	30.98
Operating Expense	25.72	20.92	22.73
Net Profit	6.38	8.80	5.79
Net Profit Margin	18.35	26.49	18.69
Earning Per Share	17.86	24.64	16.20
EBIDTA	9.03	12.27	8.27
Effective Tax Rate	23.54	23.98	24

Particulars	Sep 2024
Revenue	34.77
Operating Expense	25.72
Net Profit	6.38
Net Profit Margin	18.35
Earning Per Share	17.86
EBIDTA	9.03
Effective Tax Rate	23.54

Coral Laboratories Ltd Profit & Loss

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2024	Mar 2023	Mar 2022
Total Revenue Annual	83.66	78.12	75.61
Operating Expenses Annual	67.42	74.31	67.40
Operating Profit Annual	22.71	10.74	13.99
Interest Annual	0.00	0.34	0.14
Depreciation	1.97	2.17	1.98
Net Profit Annual	15.79	6.45	9.05
Tax Annual	4.94	1.78	2.81

Particulars	Mar 2024
Total Revenue Annual	83.66
Operating Expenses Annual	67.42
Operating Profit Annual	22.71
Interest Annual	0.00
Depreciation	1.97
Net Profit Annual	15.79
Tax Annual	4.94

Coral Laboratories Ltd Cash Flow

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2024	Mar 2023	Mar 2022
Cash Flow at the Beginning	6.13	2.51	2.32
Cash Flow from Operations	-5.46	12.67	6.08
Cash Flow from Investing	1.40	-2.61	-6.05
Cash Flow from Financing	0.01	-6.43	0.15
Cash Flow at the End	2.07	6.13	2.51

Particulars	Mar 2024
Cash Flow at the Beginning	6.13
Cash Flow from Operations	-5.46
Cash Flow from Investing	1.40
Cash Flow from Financing	0.01
Cash Flow at the End	2.07

Coral Laboratories Ltd Key Ratios

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2024	Mar 2023	Mar 2022
PBDIT Margin (%)	27.15	13.76	18.50
PBIT Margin (%)	24.78	10.97	15.87
PBT Margin (%)	24.78	-21.30	-97.49
Net PROFIT Margin (%)	18.87	8.26	11.97
Return On Networth / Equity (%)	9.50	4.15	6.18
Return On Networth /Employed (%)	12.26	5.23	7.70
Return On Assets (%)	9.25	3.96	5.86
Total Debt / Equity (X)	TBA	0.02	0.04
Asset Turnover Ratio (%)	0.49	0.48	0.49

Particulars	Mar 2024
PBDIT Margin (%)	27.15
PBIT Margin (%)	24.78
PBT Margin (%)	24.78
Net PROFIT Margin (%)	18.87
Return On Networth / Equity (%)	9.50
Return On Networth /Employed (%)	12.26
Return On Assets (%)	9.25
Total Debt / Equity (X)	TBA
Asset Turnover Ratio (%)	0.49

Coral Laboratories Ltd Balance Sheet

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2024	Mar 2023	Mar 2022
Fixed Assets Annual	23.34	24.30	22.79
Total Current Assets Annual	153.85	123.54	130.80
Non Current Assets Annual	51.83	50.81	59.09
Total Shareholders Funds Annual	177.50	154.80	156.05
Total Assets Annual	205.68	174.35	189.90

Particulars	Mar 2024
Fixed Assets Annual	23.34
Total Current Assets Annual	153.85
Non Current Assets Annual	51.83
Total Shareholders Funds Annual	177.50
Total Assets Annual	205.68

Coral Laboratories Ltd Earning Calls

No Data Availabe

Dividend Pages

PE Ratio

Get Your FAQs Right

As of Jan 15, 2025, Coral Laboratories Ltd has a market capitalization of 132.59 Cr. Value Research classifies it as a Micro-Cap company.

Yes, Coral Laboratories Ltd is debt-free with a debt-to-equity ratio of 0.00.

In FY 2024 , Coral Laboratories Ltd recorded a total revenue of approximately 83.66 Cr marking a significant milestone in the company's financial performance.

Coral Laboratories Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately 0.2% and 0.1% annually, respectively..

Coral Laboratories Ltd's current PE ratio is 8.40.

Coral Laboratories Ltd's ROCE averaged 8.2% from the FY ending March 2022 to 2024, with a median of 7.4%. It peaked at 11.7% in March 2024, reflecting strong capital efficiency over the period..

Coral Laboratories Ltd's latest EBIT is Rs. 20.73 Cr, surpassing the average EBIT of Rs. 13.77 Cr over the 5 years..